RED Oncology GmbH

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer1 trial
• Obesity1 trial
• Type 2 diabetes1 trial

Phase

• Phase 33 trials

Status

• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• Eli Lilly and Company2 trials
• Technische Universitat Dresden1 trial

Running trials

• Active, not recruiting

  A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity

  NCT06662383· Phase 3· Eli Lilly and Company· Source

Closed trials

• Completed

  A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin

  NCT06192108· Phase 3· Eli Lilly and Company· Source

• Completed

  CIRCULATE

  NCT04089631· Phase 3· Technische Universitat Dresden· Source